Imunon, Inc. — Director's Dealing 2022

Apr 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2022-04-12

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-12	Celsion Corporation Common Stock	P	4000	$3.5323	Acquired	16513	Direct

Footnotes

F1: The shares were purchased on the open market.